Skip to main content
Log in

Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation

  • Original Article
  • Published:
Transplant International

Abstract

Recurrence of primary focal glomerulosclerosis (FGS) after renal transplantation is associated with poor graft survival. Plasma exchange (PE) can reduce proteinuria and even induce complete remission of proteinuria. It is, however, unknown whether the use of PE therapy improves long-term graft survival. In our center, PE has been used to treat recurrent FGS after renal transplantation since 1994. Thus far, 13 patients have been treated with PE for recurrent FGS and followed for up to 77 months after the onset of the recurrence. We reviewed the transplantation data in these patients, and, for comparison, ten patients who underwent transplantation between 1973 and 1991 and were not treated with PE served as historical controls. Recurrence of FGS occurred within 4 weeks of transplantation in 74% of the patients. PE was started within 14 days of the onset of proteinuria in 85% of the patients. Two patients lost their graft within the first month of transplantation due to untreatable rejection; the remaining 11 patients (85%) achieved complete (n=7) or partial (n=4) remission. Seven patients remained in remission after a short period of treatment with PE (≤18 sessions in 2 months), whereas four patients needed prolonged treatment (median of 58 sessions). The need for prolonged PE was associated with a late (>30 days after transplantation) recurrence of FGS (P=0.02). A comparison with the historical control group revealed not only a significant reduction in proteinuria, but also significantly better long-term graft survival in the treated group, 85% and 30%, respectively, at 5 years (P=0.02). In conclusion, PE is an effective form of treatment for recurrent FGS, especially if initiated early. Failure to maintain stable remission after the initial period of PE does not necessarily imply a poor outcome, and sustained remissions can be achieved after prolonged treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Chabdan S. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 2001; 12:394.

    PubMed  Google Scholar 

  2. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92:375.

    CAS  PubMed  Google Scholar 

  3. Dantal J, Baatard R, Hourmant M, Cantarovich D, Buzelin F, Soulillou JP. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. Transplantation 1991; 52:827.

    CAS  PubMed  Google Scholar 

  4. Pinto J, Lacerda G, Cameron JS, Turner DR, Bewick CS, Ogg CS. Recurrence of focal and segmental glomerulosclerosis in renal allografts. Transplantation 1981; 32:83.

    CAS  PubMed  Google Scholar 

  5. Briggs J, Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. Nephrol Dial Transplant 1999; 14:564.

    Article  CAS  PubMed  Google Scholar 

  6. Dantal J, Soulillou JP. Relapse of focal segmental glomerulosclerosis after kidney transplantation. Adv Nephrol Necker Hosp 1996; 25:91.

    CAS  PubMed  Google Scholar 

  7. Cameron JS, Senguttuvan P, Hartley B, et al. Focal segmental glomerulosclerosis in 59 renal allografts from a single centre. Analysis of risk factors for recurrence. Transplant Proc 1989; 21:2117.

    CAS  PubMed  Google Scholar 

  8. Vincenti F, Biava C, Tomlanovich S, et al. Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation. Transplantation 1989; 47:595.

    CAS  PubMed  Google Scholar 

  9. Banfi G, Colturi C, Montagnino G, Ponticelli C. The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation 1990; 50:594.

    CAS  PubMed  Google Scholar 

  10. Pirson Y, Squifflet JP, Marbaix E, Alexandre GP, van Ypersele de Strihou C. Recurrence of focal segmental glomerulosclerosis despite cyclosporine treatment after renal transplantation. BMJ 1986; 292:1336.

    CAS  Google Scholar 

  11. Voets AJ, Hoitsma AJ, Koene RAP. Recurrence of nephrotic syndrome during cyclosporine treatment after renal transplantation (letter). Lancet 1986; 327:266.

    Article  Google Scholar 

  12. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334:878.

    Article  CAS  PubMed  Google Scholar 

  13. Andresdottir MB, Ajubi N, Croockewit S, Assmann KJM, Hillbrands LB, Wetzels JFM. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999; 14:2650.

    Article  CAS  PubMed  Google Scholar 

  14. Greenstein SM, Delrio M, Ong E, et al. Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol 2000; 14:1061.

    Google Scholar 

  15. Dall’Amico R, Ghiggeri G, Carraro M, et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999; 34:1048.

    CAS  PubMed  Google Scholar 

  16. Laufer J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN. Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 1988; 46:540.

    CAS  PubMed  Google Scholar 

  17. Matalon A, Markowitz GS, Joseph RE, et al. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol 2001; 56:271.

    CAS  PubMed  Google Scholar 

  18. Hoitsma AJ, Wetzels JFM, van Lier HJJ, Berden JHM, Koene RAP. Cyclosporine treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients. Lancet 1987; 339:584.

    Article  Google Scholar 

  19. Hilbrands LB, Hoitsma AJ, Koene RAP. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after transplantation. Transplantation 1996; 61:1038.

    Google Scholar 

  20. de Sevaux RG, Gregoor PJ, Hene RJ, et al. A controlled trial comparing two doses of cyclosporine in conjunction with mycophenolate mofetil and corticosteroids. J Am Soc Nephrol 2001; 12:1750.

    PubMed  Google Scholar 

  21. Striegel JE, Sibley RK, Fryd DS, Mauer M. Recurrence of focal segmental glomerulosclerosis in children following renal transplantation. Kidney Int Suppl 1986; 19: S44.

    CAS  PubMed  Google Scholar 

  22. Kim EM, Striegel J, Kim Y, Matas AJ, Najarian JS, Mauer SM. Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int 1994; 45:1440.

    CAS  PubMed  Google Scholar 

  23. Revillard JP, Manuel Y, Betuel H, Fries D, Treager J. Proteinuria in human renal allografts: sequential studies. In: Manuel Y, Revillard JP, Betuel H, eds. Proteins in normal and pathological urine. Baltimore: University Park Press, 1970: 309.

  24. Verani RR, Hawkins EP. Recurrent focal segmental glomerulosclerosis: a pathological study of the early lesion. Am J Nephrol 1986; 6:263.

    CAS  PubMed  Google Scholar 

  25. Kaplan-Pavlovcic S, Ferluga D, Hvala A, Chwatal-Lakic N, Bren AF, Vizjak A. Recurrent focal segmental glomerulosclerosis after renal transplantation: is early recurrent proteinuria always a surrogate marker for recurrence of the disease? Transplant Proc 2002; 34:3122.

    Article  CAS  PubMed  Google Scholar 

  26. Artero M, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23:574.

    CAS  PubMed  Google Scholar 

  27. Deegens J, Wetzels J. Treatment of recurrent focal glomerulosclerosis after renal transplantation: is prednisone essential to maintain a sustained remission? Transplantation 2003; 75:1080.

    Article  PubMed  Google Scholar 

  28. Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330:7.

    Article  CAS  PubMed  Google Scholar 

  29. Cochat P, Kassir A, Colon S, et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmapheresis and cyclophosphamide. Pediatr Nephrol 1993; 7:50.

    CAS  PubMed  Google Scholar 

  30. Salomon R, Gagnadoux M, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003; 75:810.

    Article  CAS  PubMed  Google Scholar 

  31. Cheong HI, Han HW, Park HW, et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000; 15:78.

    Google Scholar 

Download references

Acknowledgements

We thank Dr. A. Hoitsma for providing survival data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeroen K. J. Deegens.

About this article

Cite this article

Deegens, J.K.J., Andresdottir, M.B., Croockewit, S. et al. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation. Transpl Int 17, 151–157 (2004). https://doi.org/10.1007/s00147-003-0679-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00147-003-0679-y

Keywords

Navigation